This review highlights that while beta-blockers and verapamil remain standard for MAT rate control, intravenous magnesium and novel ablation techniques offer promising alternatives for drug-resistant cases.
No takes yet. Share an insight, caveat, or question.
Supports guideline-recommended beta-blockers and verapamil for MAT rate control; leaves open magnesium and ablation efficacy pending prospective trials.
Elpidio Santillo (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: